Janus Henderson Group PLC Boosts Stock Position in Calumet, Inc. $CLMT

Janus Henderson Group PLC raised its position in shares of Calumet, Inc. (NASDAQ:CLMT) by 596.3% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 217,948 shares of the oil and gas company’s stock after buying an additional 186,648 shares during the period. Janus Henderson Group PLC’s holdings in Calumet were worth $7,824,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the company. Renaissance Technologies LLC acquired a new stake in Calumet in the first quarter valued at approximately $14,066,000. Hsbc Holdings PLC acquired a new position in shares of Calumet during the first quarter worth $3,059,000. Vanguard Group Inc. lifted its holdings in shares of Calumet by 1.3% during the 4th quarter. Vanguard Group Inc. now owns 4,703,040 shares of the oil and gas company’s stock valued at $93,449,000 after purchasing an additional 58,376 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund boosted its position in shares of Calumet by 107.0% in the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 97,741 shares of the oil and gas company’s stock worth $3,509,000 after purchasing an additional 50,530 shares in the last quarter. Finally, First Trust Advisors LP boosted its position in shares of Calumet by 36.2% in the 1st quarter. First Trust Advisors LP now owns 347,486 shares of the oil and gas company’s stock worth $12,475,000 after purchasing an additional 92,368 shares in the last quarter. 34.41% of the stock is currently owned by institutional investors.

Calumet Stock Performance

Calumet stock opened at $40.26 on Thursday. The business’s 50-day simple moving average is $37.77 and its two-hundred day simple moving average is $32.43. The company has a market cap of $3.51 billion, a PE ratio of -18.64 and a beta of 0.71. Calumet, Inc. has a fifty-two week low of $12.94 and a fifty-two week high of $45.20.

Calumet (NASDAQ:CLMT) last announced its quarterly earnings data on Friday, May 8th. The oil and gas company reported ($3.64) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.33) by ($3.31). The firm had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $1 billion. During the same period last year, the firm posted ($1.87) EPS. The firm’s revenue was up 3.6% on a year-over-year basis. As a group, analysts predict that Calumet, Inc. will post -0.13 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Daniel J. Sajkowski sold 4,240 shares of the stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $36.16, for a total value of $153,318.40. Following the transaction, the director owned 77,718 shares in the company, valued at approximately $2,810,282.88. This represents a 5.17% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder Group Heritage sold 626,998 shares of the firm’s stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $32.54, for a total transaction of $20,402,514.92. Following the transaction, the insider directly owned 12,980,211 shares of the company’s stock, valued at $422,376,065.94. This represents a 4.61% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 3.15% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several research analysts recently issued reports on CLMT shares. TD Cowen reaffirmed a “hold” rating on shares of Calumet in a research report on Wednesday, June 3rd. Weiss Ratings raised Calumet from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, May 11th. Finally, The Goldman Sachs Group boosted their price target on Calumet from $36.00 to $40.00 and gave the stock a “neutral” rating in a research note on Thursday, July 30th. One analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $37.75.

Calumet Company Profile

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.